Literature DB >> 12767665

Can an energy-deficient heart grow bigger and stronger?

Robert Roberts, Ali J Marian.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12767665      PMCID： PMC2910249          DOI： 10.1016/s0735-1097(02)03008-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  22 in total

Review 1.  The molecular genetic basis for hypertrophic cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

2.  An increase in the myocardial PCr/ATP ratio in GLUT4 null mice.

Authors:  Robert G Weiss; John C Chatham; Dimitrios Georgakopolous; Maureen J Charron; Theo Wallimann; Laurence Kay; Bernd Walzel; Yibin Wang; David A Kass; Gary Gerstenblith; V P Chacko
Journal:  FASEB J       Date:  2002-04       Impact factor: 5.191

3.  Proton-decoupled myocardial 31P NMR spectroscopy reveals decreased PCr/Pi in patients with severe hypertrophic cardiomyopathy.

Authors:  L Sieverding; W I Jung; J Breuer; S Widmaier; A Staubert; F van Erckelens; O Schmidt; M Bunse; T Hoess; O Lutz; G J Dietze; J Apitz
Journal:  Am J Cardiol       Date:  1997-08-04       Impact factor: 2.778

4.  Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.

Authors:  M H Gollob; M S Green; A S Tang; T Gollob; A Karibe; A S Ali Hassan ; F Ahmad; R Lozado; G Shah; L Fananapazir; L L Bachinski; R Roberts; A S Hassan
Journal:  N Engl J Med       Date:  2001-06-14       Impact factor: 91.245

Review 5.  Myocardial energetics in cardiac hypertrophy.

Authors:  Jianyi Zhang
Journal:  Clin Exp Pharmacol Physiol       Date:  2002-04       Impact factor: 2.557

6.  Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.

Authors:  E Blair; C Redwood; H Ashrafian; M Oliveira; J Broxholme; B Kerr; A Salmon; I Ostman-Smith; H Watkins
Journal:  Hum Mol Genet       Date:  2001-05-15       Impact factor: 6.150

Review 7.  Cardiac disease in myotonic dystrophy.

Authors:  M F Phillips; P S Harper
Journal:  Cardiovasc Res       Date:  1997-01       Impact factor: 10.787

8.  31P MR spectroscopy in hypertrophic cardiomyopathy: comparison with Tl-201 myocardial perfusion imaging.

Authors:  H Sakuma; K Takeda; T Tagami; T Nakagawa; S Okamoto; T Konishi; T Nakano
Journal:  Am Heart J       Date:  1993-05       Impact factor: 4.749

9.  31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy.

Authors:  W I Jung; L Sieverding; J Breuer; T Hoess; S Widmaier; O Schmidt; M Bunse; F van Erckelens; J Apitz; O Lutz; G J Dietze
Journal:  Circulation       Date:  1998-06-30       Impact factor: 29.690

10.  Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy.

Authors:  Jenifer G Crilley; Ernest A Boehm; Edward Blair; Bheeshma Rajagopalan; Andrew M Blamire; Peter Styles; William J McKenna; Ingegerd Ostman-Smith; Kieran Clarke; Hugh Watkins
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094
View more
  2 in total

1.  Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome.

Authors:  Jasvinder S Sidhu; Yadavendra S Rajawat; Tapan G Rami; Michael H Gollob; Zhinong Wang; Ruiyong Yuan; A J Marian; Francesco J DeMayo; Donald Weilbacher; George E Taffet; Joanna K Davies; David Carling; Dirar S Khoury; Robert Roberts
Journal:  Circulation       Date:  2004-12-20       Impact factor: 29.690

2.  Molecular Genetic Basis of Hypertrophic Cardiomyopathy.

Authors:  A J Marian
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.